Phages for All: How to Build an Infrastructure for Phage Therapy in Resource-Limited Settings

Time: 12:00 pm
day: Day One


  • In-country partnerships and collaborations are key to setting up sustainable infrastructure for a new drug modality
  • Cost is the main challenge and must be considered during product development
  • Emerging markets are an incredible opportunity for antimicrobials such as phage